Table 2.
Whole cohort | PSM |
P-value | ||
---|---|---|---|---|
Characteristics | Univariate analysis HR (95% CI) | |||
Age (years) | 1.014 (0.996–1.033) | 0.135 | 1.017 (0.991–1.044) | 0.201 |
Sex | ||||
Females | 1 | 1 | ||
Male | 0.955 (0.544–1.675) | 0.872 | 1.065 (0.492–2.307) | 0.872 |
Diabetes, yes | 0.943 (0.537–1.655) | 0.838 | 0.980 (0.467–2.059) | 0.958 |
Etiology | ||||
Others | 1 | 1 | ||
Alcohol | 0.846 (0.544–1.316) | 0.458 | 0.878 (0.469–1.645) | 0.684 |
Hemoglobin (g/dL) | 0.959 (0.871–1.057) | 0.402 | 0.912 (0.793–1.050) | 0.201 |
TLC (per mm3) | 0.991 (0.947–1.036) | 0.692 | 1.002 (0.945–1.063) | 0.950 |
Platelet count ( × 103/mm3) | 1.000 (0.997–1.002) | 0.760 | 0.999 (0.996–1.003) | 0.651 |
INR | 1.191 (1.062–1.337) | 0.003 | 1.133 (0.945–1.359) | 0.178 |
Total bilirubin (mg/dL) | 1.041 (0.989–1.097) | 0.123 | 1.095 (1.025–1.169) | 0.007 |
Creatinine (mg/dl) | 1.219 (1.065–1.397) | 0.004 | 1.239 (0.931–1.648) | 0.142 |
AST (IU/L) | 1.001 (0.998–1.003) | 0.631 | 0.998 (0.991–1.005) | 0.625 |
ALT (IU/L) | 1.000 (0.998–1.003) | 0.811 | 0.996 (0.984–1.008) | 0.504 |
Alk P (IU/L) | 1.002 (1.001–1.003) | 1.001 (0.999–1.003) | 0.287 | |
Albumin (g/dL) | 0.598 (0.424–0.842) | 0.003 | 0.512 (0.325–0.807) | 0.004 |
CTP | 1.224 (1.122–1.336) | <0.001 | 1.307 (1.154–1.480) | <0.001 |
Child class | ||||
A | 1 | 1 | ||
B | 2.684 (1.277–5.642) | 0.009 | 4.415 (1.493–13.055) | 0.007 |
C | 4.680 (2.268–9.657) | <0.001 | 8.098 (2.750–23.848) | <0.001 |
MELD | 1.068 (1.034–1.103) | <0.001 | 1.074 (1.029–1.121) | 0.001 |
COVID-19 | ||||
No | 1 | 1 | ||
Yes | 0.775 (0.474–1.268) | 0.331 | 1.224 (0.663–2.263) | 0.520 |
Abbreviations: TLC, total leukocyte count; INR, international normalized ratio; ALT, alanine aminotransferase; Alk P, alkaline phosphatase; AST, aspartate aminotransferase; CTP, Child-Turcotte-Pugh; MELD, model for end-stage liver disease.